US Stock MarketDetailed Quotes
AXIM AXIM BIOTECHNOLOGIES INC
- 0.014300
- -0.000500-3.38%
15min DelayClose Jul 29 16:00 ET
4.17MMarket Cap-510P/E (TTM)
0.014300High0.013200Low4.65KVolume0.013200Open0.014800Pre Close62.10Turnover0.00%Turnover RatioLossP/E (Static)291.46MShares0.03290052wk High-0.55P/B3.10MFloat Cap0.00500052wk Low--Dividend TTM216.91MShs Float1.220000Historical High--Div YieldTTM7.43%Amplitude0.005000Historical Low0.013000Avg Price1Lot Size
AXIM BIOTECHNOLOGIES INC Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -651.67%-1.07M | 49.59%-1.03M | 106.20%19.56K | 17.66%-264.5K | 8.56%-643.59K | 79.83%-141.96K | 17.53%-2.04M | 60.04%-315.51K | 39.71%-321.23K | -18.19%-703.88K |
| Net income from continuing operations | 89.42%-292.3K | -29.10%-8.06M | -111.58%-1.9M | 116.14%328.47K | -204.53%-3.72M | -32.39%-2.76M | 61.06%-6.24M | 88.83%-899.05K | 38.19%-2.03M | 68.05%-1.22M |
| Operating gains losses | -117.39%-340.75K | 714.48%3.07M | 58.23%-91.08K | -518.04%-1.03M | 4,562.48%2.23M | 440.10%1.96M | -131.47%-499.45K | -521.27%-218.06K | --246.74K | --47.88K |
| Depreciation and amortization | 1.17%108.01K | 0.21%427.02K | -0.08%106.75K | 0.01%106.76K | 0.70%106.76K | 0.21%106.76K | -79.86%426.13K | -85.97%106.84K | -84.75%106.74K | -83.64%106.01K |
| Other non cash items | 505.96%538.42K | -3.85%2.04M | 2,617.58%1.18M | -88.28%49.3K | 219.29%720.66K | -94.18%88.86K | -23.25%2.13M | -113.73%-47.04K | -65.69%420.6K | -80.38%225.71K |
| Change In working capital | -400.91%-1.09M | 24.33%1.29M | 31.58%687.68K | -42.18%244.04K | 96.07%-1.69K | 162.89%362.25K | 3,788.24%1.04M | 1,075.97%522.63K | 490.34%422.05K | 77.79%-43.06K |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%20.09K | ---- | ---- | ---- |
| -Change in prepaid assets | -71.33%43K | 1,040.24%521.93K | 1,421.05%489.48K | 875.06%32.45K | -64.80%-150K | --150K | 80.49%-55.51K | 112.17%32.18K | -97.16%3.33K | 55.71%-91.02K |
| -Change in payables and accrued expense | -591.73%-1.08M | 6.83%790.53K | -28.66%202.75K | -12.93%236.6K | 185.91%131.53K | 59.11%219.65K | 166.66%740.01K | 479.08%284.22K | 160.88%271.74K | 620.27%46K |
| -Change in other current assets | ---- | 477.60%9.83K | 77.19%3.01K | --0 | ---- | ---- | --1.7K | --1.7K | --0 | --0 |
| -Change in other working capital | -616.22%-52.98K | -109.01%-30K | -104.10%-7.56K | -117.02%-25.01K | --9.97K | ---7.4K | --333.13K | --184.44K | --146.98K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -651.67%-1.07M | 49.59%-1.03M | 106.20%19.56K | 17.66%-264.5K | 8.56%-643.59K | 79.83%-141.96K | 17.79%-2.04M | 60.21%-315.51K | 39.71%-321.23K | -18.19%-703.88K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2.84K | 0 | 0 | 0 | 82.75%-8.71K | 0 | 72.90%-2.71K | |||
| Net PPE purchase and sale | ---2.84K | --0 | --0 | --0 | ---- | ---- | 78.49%-8.71K | --0 | ---2.71K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---2.84K | --0 | --0 | --0 | --0 | --0 | 82.75%-8.71K | --0 | 72.90%-2.71K | -1,466.58%-6K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 581.53%1.01M | -30.82%1.14M | -42.89%113.68K | -54.98%190.23K | 87.34%687.55K | -77.50%148.22K | -34.97%1.65M | -78.55%199.04K | -37.78%422.52K | 5.19%367K |
| Net issuance payments of debt | --100K | 8,331.71%675K | 1,225.62%100K | --0 | ---- | ---- | -100.92%-8.2K | -100.97%-8.88K | 129.61%8.88K | --0 |
| Net common stock issuance | 420.09%910.15K | -71.79%491.46K | -94.17%13.68K | -63.50%190.23K | -60.70%112.55K | -75.00%175K | 6.53%1.74M | 472.81%234.84K | -29.77%521.16K | 14.55%286.39K |
| Net other financing activities | ---- | 69.11%-26.78K | --0 | --0 | --0 | 18.53%-26.78K | -1,255.46%-86.71K | 18.45%-26.92K | -225.77%-107.53K | -18.48%80.61K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 581.53%1.01M | -30.82%1.14M | -42.89%113.68K | -54.98%190.23K | 87.34%687.55K | -77.50%148.22K | -34.97%1.65M | -78.55%199.04K | -37.78%422.52K | 5.19%367K |
| Net cash flow | ||||||||||
| Beginning cash position | 230.90%156.46K | -89.56%47.28K | -85.82%23.22K | 49.62%97.5K | -86.88%53.54K | -89.56%47.28K | -0.92%452.96K | -51.61%163.75K | -67.77%65.16K | -9.17%408.04K |
| Current changes in cash | -1,054.41%-59.75K | 126.91%109.18K | 214.40%133.24K | -175.35%-74.28K | 112.82%43.96K | 113.94%6.26K | -9,517.85%-405.68K | -201.64%-116.46K | -27.61%98.58K | -38.80%-342.88K |
| End cash Position | 80.63%96.71K | 230.90%156.46K | 230.90%156.46K | -85.82%23.22K | 49.62%97.5K | -86.88%53.54K | -89.56%47.28K | -89.56%47.28K | -51.61%163.75K | -67.77%65.16K |
| Free cash flow | -653.67%-1.07M | 49.81%-1.03M | 106.20%19.56K | 18.35%-264.5K | 9.34%-643.59K | 79.83%-141.96K | 19.08%-2.05M | 61.21%-315.51K | 40.33%-323.94K | -19.12%-709.88K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg